Home Blood / Hematology Dr. Usmani on Impact of BCMA on the Myeloma Treatment Landscape

Dr. Usmani on Impact of BCMA on the Myeloma Treatment Landscape

85
0

Saad Z. Usmani, MD, FACP, chief of Plasma Cell Disorder, director of Clinical Research in Hematologic Malignancies, Levine Cancer Institute, Atrium Health, discusses how the target BCMA is impacting the multiple myeloma treatment landscape.

<<< 17th International Myeloma Workshop

This site uses Akismet to reduce spam. Learn how your comment data is processed.